- Global Pharma News & Resources

Appointment of Chief Operating Officer

Accomplished technology executive and innovator Dr. Niko Pagoulatos joins Spectral MD


LONDON, U.K AND DALLAS, TX, U.S. – Spectral MD Holdings, Ltd. (AIM: SMD), a predictive analytics company with proprietary AI algorithms and optical technology for rapid and accurate treatment decisions in wound care, announces the appointment of Dr. Niko Pagoulatos as Chief Operating Officer, effective this week.


As Chief Operating Officer of Spectral MD, reporting to CEO Wensheng Fan, Dr. Pagoulatos will accelerate growth and operational performance of the Company with specific focus on scientific research, engineering, product development leading to global portfolio launch and clinical adoption.


Dr. Pagoulatos comes to Spectral MD as an accomplished technology executive and innovator with 25+ years of experience in engineering, clinical and business aspects of specialized medical ultrasound imaging. Dr. Pagoulatos is a team-oriented and results-driven leader with extensive experience and a strong track record in building and leading cross-functional teams to successfully commercialize innovative medical technologies with global clinical impact.


Dr. Pagoulatos has held multiple executive roles including Chief Innovation Officer, Chief Operating Officer, and most recently, Chief Technology Officer at EchoNous, a global healthcare innovation company headquartered in Seattle focused on the development and commercialization of the first AI-assisted handheld ultrasound tool to increase diagnostic confidence at the bedside.


Dr. Pagoulatos earned his B.S. in Physics from the University of Athens in Greece and completed his graduate studies at the University of Washington in Seattle, where he earned a M.S. in Bioengineering in addition to a M.S. and Ph.D. in Electrical Engineering.


Niko Pagoulatos, Chief Operating Officer of Spectral MD, said: “I am impressed with Spectral MD’s wound healing assessment breakthrough technology, and I am excited to join its world-class team. I look forward to applying my experience and expertise to help Spectral MD build on its success, release its breakthrough DeepView™ technology into the market, and execute on its strategic goals to revolutionize wound care management worldwide.”


Wensheng Fan, Chief Executive Officer of Spectral MD, said: “Niko is a transformational leader and proven industry innovator with deep experience in medical ultrasound imaging, product innovation, and groundbreaking AI solutions. As an innovative and seasoned executive, I am confident his broad operational experience will be critically important as we continue to manage our growth, scaleup operations and seek to bring DeepView™ through development and into the market. I am truly delighted to welcome Niko to the Spectral MD team."

Editor Details

  • Name:
    • Sam Allen
Last Updated: 09-Nov-2022